Stanford Team Publishes Validation of Circulating DNA Sequencing for Heart Transplant Rejection Dx | GenomeWeb

NEW YORK (GenomeWeb) – A Stanford University method for sequencing circulating DNA to non-invasively detect heart transplant rejection has proved itself equal in accuracy to gold standard endomyocardial biopsy-based testing in a prospective study of 65 transplant patients.

The study, by a team led by Stanford's Stephen Quake and Kiran Khush, was published today in Science Translational Medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.